Endemic Pemphigus Foliaceous is a chronic autoimmune bullous skin disease. Treatment with prednisone often produces excellent results, but resistant forms exist, requiring alternative therapy. Alternative treatments have been used in cases of corticosteroid-refractory pemphigus, showing favorable results. This case study focuses on an adolescent male with a clinical-pathological diagnosis of pemphigus foliaceous with a severe clinical form of erythrodermis, unresponsive to multiple therapies, but which showed a satisfactory outcome with intravenous immunoglobulin. In this case we highlight the fact that the patient was a teenager who showed substantial clinical improvement as the result of using intravenous immunoglobulin, followed by complete remission after the fourth cycle of medication, allowing reduced doses of steroids and a consequent reduction of side effects. © 2011 by Anais Brasileiros de Dermatologia.
CITATION STYLE
Teixeira, T. A., Silvestre, M. C., Maciel, V. G., Fiori, F. C. B. da C., Borges, C. de B., & Costa, M. B. (2011). Refractory endemic pemphigus foliaceous in adolescence successfully treated with intravenous immunoglobulin. Anais Brasileiros de Dermatologia, 86(4 SUPPL. 1), 133–136. https://doi.org/10.1590/s0365-05962011000700035
Mendeley helps you to discover research relevant for your work.